in a multicentric prospective study should be tested clinically the effectiveness and the tolerance of an angiotensin-ii-antagonist ( saralasin-iwf ) developed by the institut fur wirkstofforschung der akademie der wissenschaften , its position in the differential-diagnostic step programme of the arterial hypertension should be analysed and with it should be performed pathogenetic investigations for hypertension after kidney transplantation .
C0003009
angiotensin-ii
C0036193
saralasin